Jed Fahey names several reliable supplemental sources of sulforaphane
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus (Mounjaro) and for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity (Zepbound)
Saxenda remains a reasonable option for patients who cannot access or tolerate semaglutide, and it has the longest safety track record in the weight management space
Following the release of a drug, the FAERS database collects adverse events reports from providers and patients that are witnessed in-market (i.e., in the real world practice of medicine rather than during a clinical trial or drug testing process)
A promotes CD38 expression in senescent microglia in Alzheimers disease
In the case of naltrexone-bupropion, bupropion is known for its use as a single agent for depression and for smoking cessation and has been found to promote weight loss at 300 or 400 mg daily